InnoCare
China - BeijingBiotechnology
Focus: InnoCare is a Beijing-based oncology-focused biotech company founded in 2024, now publicly listed with a diversified pipeline spanning cancer, immunology, and dermatology indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About InnoCare
AI assessmentNot HiringNo open roles listed right now. Follow InnoCare to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
[14C]ICP-022
Healthy VolunteersClinical Trials (1)
NCT04441450ADME Study of [14C]ICP-022 in Healthy Males
N/AHelp build intelligence for InnoCare
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.